0001113232 false 0001113232 false 0001113232 2020-11-05 2020-11-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 5, 2020

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-30941   34-1818596
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts   01915
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:  (978) 787-4000

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition 

 

On November 5, 2020, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter ended September 30, 2020. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
     
99.1   Press Release dated November 5, 2020. Filed herewith.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 5, 2020 Axcelis Technologies, Inc.
   
  By: /s/ KEVIN J. BREWER
    Kevin J. Brewer
    Executive Vice President
    and Chief Financial Officer

 

3

 

 

Exhibit 99.1

 

News Release

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2020

 

Company Reports Strong Earnings Driven by Robust Gross Margins

 

BEVERLY, Mass. — Nov. 5, 2020—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2020.

 

The Company reported third quarter revenue of $110.4 million, compared to $123 million for the second quarter of 2020. Operating profit for the quarter was $13.9 million, compared to $16.4 million for the second quarter. Net income for the quarter was $10.8 million, or $0.32 per diluted share, compared to net income for the second quarter of $13.3 million, or $0.39 per diluted share. Gross margin for the quarter was 43.6%, compared to 42.2% in the second quarter. Cash, cash equivalents and restricted cash were $212.7 million on September 30, 2020, compared to $197 million on June 30, 2020.

 

President and CEO Mary Puma commented, “We are pleased with our third quarter performance, which met or exceeded guidance and consensus. The Company delivered strong earnings driven by robust gross margins. We continue to expand our large and diverse customer base in key market segments, with new penetrations of the Purion H and new Purion product extensions. We are exiting 2020 with good momentum, positioning us well to capitalize on the expectation that 2021 will be a strong investment year and for the achievement of our $550 and $650 million dollar target models over the next several years.”

 

Business Outlook

 

For the fourth quarter ending December 31, 2020, Axcelis expects revenues to be approximately $110 million with gross margin around 41%. Fourth quarter operating profit is forecasted to be approximately $10 million with earnings per diluted share of approximately $0.21.

 

Third Quarter 2020 Conference Call

 

The Company will host a call to discuss the results for the third quarter 2020 on Friday, November 6, 2020 at 8:30 am ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com. If you would like to ask a question, the dial in number is 866.588.8911 (707.294.1561 outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and Conference ID: 1999553. Please dial in at least 15 minutes in advance to ensure a timely connection to the call. Webcast replays will be available for 30 days following the call.

 

 

 

 

News Release

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

Company Contacts

 

Investor Relations:

Doug Lawson
978.787.9552

 

Editorial/Media:

Maureen Hart
978.787.4266

 

 

 

 

News Release

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2020   2019   2020   2019 
Revenue:                
Product  $104,799   $64,290   $334,126   $217,201 
Services   5,606    5,163    18,235    18,034 
Total revenue   110,405    69,453    352,361    235,235 
Cost of revenue:                    
Product   56,427    33,587    189,118    118,105 
Services   5,817    5,285    17,634    17,294 
Total cost of revenue   62,244    38,872    206,752    135,399 
Gross profit   48,161    30,581    145,609    99,836 
Operating expenses:                    
Research and development   14,867    12,930    45,513    40,335 
Sales and marketing   9,763    8,057    27,404    25,411 
General and administrative   9,649    7,707    28,726    23,097 
Total operating expenses   34,279    28,694    101,643    88,843 
Income from operations   13,882    1,887    43,966    10,993 
Other (expense) income:                    
Interest income   106    687    658    2,373 
Interest expense   (1,296)   (1,308)   (3,898)   (3,849)
Other, net   900    (890)   701    (1,252)
Total other expense   (290)   (1,511)   (2,539)   (2,728)
Income before income taxes   13,592    376    41,427    8,265 
Income tax provision (benefit)   2,807    (328)   6,119    943 
Net income  $10,785   $704   $35,308   $7,322 
Net income per share:                    
Basic  $0.32   $0.02   $1.06   $0.22 
Diluted  $0.32   $0.02   $1.04   $0.22 
Shares used in computing net income per share:                    
Basic weighted average common shares   33,477    32,344    33,159    32,584 
Diluted weighted average common shares   34,174    33,323    34,070    33,821 

 

 

 

 

News Release

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

   September 30,   December 31, 
   2020   2019 
ASSETS          
Current assets:          
Cash and cash equivalents  $211,967   $139,881 
Accounts receivable, net   45,161    83,753 
Inventories, net   159,658    140,364 
Prepaid expenses and other current assets   18,982    11,681 
Total current assets   435,768    375,679 
Property, plant and equipment, net   29,199    25,328 
Operating lease assets   4,655    5,849 
Finance lease assets, net   20,872    21,880 
Long-term restricted cash   750    6,653 
Deferred income taxes   58,247    68,060 
Other assets   41,165    44,645 
Total assets  $590,656   $548,094 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $24,260   $25,341 
Accrued compensation   18,856    7,631 
Warranty   4,151    2,759 
Income taxes   328    294 
Deferred revenue   13,118    24,601 
Current portion of finance lease obligation   705    399 
Other current liabilities   7,965    7,639 
Total current liabilities   69,383    68,664 
Long-term finance lease obligation   47,593    48,149 
Long-term deferred revenue   3,851    4,650 
Other long-term liabilities   9,166    7,204 
Total liabilities   129,993    128,667 
           
Stockholders’ equity:          
Common stock, $0.001 par value, 75,000 shares authorized; 33,491 shares issued and outstanding at September 30, 2020; 32,585 shares issued and outstanding at December 31, 2019   33    33 
Additional paid-in capital   566,195    559,878 
Accumulated deficit   (106,643)   (140,226)
Accumulated other comprehensive income (loss)   1,078    (258)
Total stockholders’ equity   460,663    419,427 
Total liabilities and stockholders’ equity  $590,656   $548,094